Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first lin ...
B2B revenue growth, in 20252026 Guidance reflects focus on high margin growth and significant core business profitability ...
According to MarketsandMarkets™, the global Workforce Management Market is projected to reach USD 13.03 billion by 2030 from USD 8.38 billion in 2025, at a CAGR of 9.2%. Browse 150 market data Tables ...
GTM Strategy & Advanced ABM track explores how top-performing B2B teams are breaking down silos to create connected programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results